Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
48.6%
% of BHCHX's 40 holdings also in IXJ
16.1%
% of IXJ's 115 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BHCHX |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY AND COMPANY | 9.3% | 8.3% | 8.3% |
|
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 4.0% | 4.0% |
|
MERCK & CO., INC. | 4.8% | 2.9% | 2.9% |
|
INTUITIVE SURGICAL, INC. | 5.8% | 2.8% | 2.8% |
|
BOSTON SCIENTIFIC CORPORATION | 5.3% | 2.3% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to IXJ
 |
ARGENX SE ADR | 4.1% |
|
UNITEDHEALTH GROUP INCORPORATED | 3.3% |
|
UNITEDHEALTH GROUP INC | 3.3% |
 |
ICON PLC | 3.2% |
|
BOSTON SCIENTIFIC CORP | 3.0% |
|
BOSTON SCIENTIFIC CORPORATION | 3.0% |
|
INTUITIVE SURGICAL, INC. | 3.0% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
VERTEX PHARMACEUTICALS INC | 3.0% |
|
VERTEX PHARMACEUTICALS INCORPORATED | 3.0% |
BHCHX Underweight Relative to IXJ
|
JOHNSON & JOHNSON | -5.4% |
|
ABBVIE INC | -4.8% |
|
ABBOTT LABORATORIES | -3.4% |
 |
NOVARTIS AG | -3.3% |
|
ROCHE HOLDING LTD | -3.2% |
 |
ASTRAZENECA PLC | -3.2% |
 |
NOVO NORDISK A/S-B | -3.1% |
|
AMGEN INC | -2.2% |
|
GILEAD SCIENCES INC | -2.0% |
|
PFIZER INC | -1.9% |